Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Baxter International, Inc. (NYSE: BAX).

Full DD Report for BAX

You must become a subscriber to view this report.

Recent News from (NYSE: BAX)

Baxter Announces U.S. FDA Clearance of New Bone Graft Substitute, Actifuse Flow
Ready-to-use synthetic bone graft substitute designed for ease of use and fast application Enhances growing osteobiologics portfolio in Baxter’s Advanced Surgery business Baxter International Inc. (NYSE:BAX), a global leader in advancing surgical innovation, today ann...
Source: Business Wire
Date: September, 06 2018 08:50
Baxter Ventures Invests In Outset Medical For Improved Renal Care Tech
Quick Take Baxter Ventures ( BAX ) has made an investment in Outset Medical ’s recent Series D funding round of $132 million. Outset Medical is in the initial commercialization stages for its new hemodialysis system. BAX isn’t a frequent strategic investor but has appa...
Source: SeekingAlpha
Date: September, 05 2018 13:16
Baxter unveils Olimel 7.6% high protein parenteral nutrition formulation at the 2018 ESPEN Congress
Baxter International (NYSE: BAX ) is showcasing OLIMEL 7.6%, the latest addition to the company’s olive oil-based parenteral nutrition portfolio, at the 40th Congress (MUTF: CACOX ) of the European Society of Clinical Nutrition and Metabolism. More news on: Baxter International In...
Source: SeekingAlpha
Date: September, 04 2018 09:05
Baxter Unveils Olimel 7.6% High Protein Parenteral Nutrition Formulation at the 2018 ESPEN Congress
Highest protein and lowest glucose formulation among Parenteral Nutrition (PN) products, available in a standardized, triple-chamber bag 1,2,3,4 New PN formulation will help meet needs of high stress patients who require more protein and are often impacted by hyperglycemia ...
Source: Business Wire
Date: September, 04 2018 08:00
Tracking George Soros's Portfolio - Q2 2018 Update
This article is part of a series that provides an ongoing analysis of the changes made to George Soros's 13F stock portfolio on a quarterly basis. It is based on George Soros's regulatory 13F Form filed on 08/16/2018. Please visit our Tracking Soros Fund Management Holdings article for an ...
Source: SeekingAlpha
Date: September, 02 2018 14:22
Gritstone Oncology Files For $80 Million U.S. IPO
Quick Take Gritstone Oncology ( GRTS ) intends to raise gross proceeds of $80 million from a U.S. IPO, according to an S-1 registration statement . The firm provides personalized immunotherapy treatments for cancer patients. GRTS has an interesting approach but hasn’t entered t...
Source: SeekingAlpha
Date: August, 24 2018 11:45
Baxter: Exit Strategy
Baxter (NYSE: BAX ) continues to be the biggest position of Dan Loeb’s hedge fund Third Point. When I acquired shares of Baxter more than a year ago, they were already trading around its then all-time high, but thanks to the strong performance throughout the year, Baxter ...
Source: SeekingAlpha
Date: August, 24 2018 10:35
1 Easy Step To Beat The Market
Today’s Market The S&P 500 ( SPY ) hit an all-time high today. Where does that leave its value? Its market cap is now 146% of GDP – a price that historically offers a prospective -2% annual return. The CAPE ratio is at 33, 94% above its historical average of 17. The prosp...
Source: SeekingAlpha
Date: August, 22 2018 09:30
FDA streamlines voluntary device malfunction reporting
The FDA has finalized its program for device makers for the voluntary reporting of device malfunctions. Manufacturers will be allowed to report certain product glitches on a quarterly basis and in summary form for certain product codes, reducing the number of required reports by about two ...
Source: SeekingAlpha
Date: August, 16 2018 10:22
Buy High Quality Stocks On Turkey-Induced Weakness - Cramer's Mad Money (8/13/18)
Stocks discussed on the in-depth session of Jim Cramer's Mad Money TV Program, Monday , August 13. It's as if the market did not already fear trade and tariffs, they have to worry about Turkey as well. Cramer thinks the Turkey currency crisis induced selloff is a buying opportunity...
Source: SeekingAlpha
Date: August, 14 2018 07:27


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator

* Cover Mode

Short Analysis provided by Squeeze Report. Get a complete short report on BAX.

About Baxter International, Inc. (NYSE: BAX)

Logo for Baxter International, Inc. (NYSE: BAX)

Not available


Contact Information



Current Management

  • Robert Parkinson / CEO, Principal Executive Officer
  • Robert J Hombach / CFO, Treasurer
  • David P. Scharf / Vice President, Secretary
  • Robert Parkinson / Chairman

Current Share Structure

  • Market Cap: $38,090,589,234 - 05/11/2018
  • Issue and Outstanding: 540,138,815 - 01/31/2018


Recent Filings from (NYSE: BAX)

Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 10 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 09 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 26 2018
Official notification to shareholders of matters to be brought to a vote (Proxy)
Filing Type: DEF 14AFiling Source: edgar
Filing Date: March, 23 2018
Additional proxy soliciting materials - definitive
Filing Type: DEFA14AFiling Source: edgar
Filing Date: March, 23 2018
Annual report with a comprehensive overview of the company
Filing Type: 10-KFiling Source: edgar
Filing Date: February, 23 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: February, 23 2018
Amendment to the SC 13G filing
Filing Type: SC 13G/AFiling Source: edgar
Filing Date: February, 12 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: February, 01 2018
Amendment to the SC 13G filing
Filing Type: SC 13G/AFiling Source: edgar
Filing Date: January, 29 2018



Daily Technical Chart for (NYSE: BAX)

Daily Technical Chart for (NYSE: BAX)

Stay tuned for daily updates and more on (NYSE: BAX)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NYSE: BAX)

Do your DD and if you choose, be ready to go!


The Research: All source information contained in this email is from the public sources mentioned below.



Thank you

DD Report



Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in BAX is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of BAX and does not buy, sell, or trade any shares of BAX. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: